Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.48 |
| ▸ | PI4KA | P42356 | 2/20 | 0.48 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.48 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.48 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.48 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.48 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.48 |
| ▸ | GAPDH | P04406 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.48 |
| ▸ | STAT6 | P42226 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17927851 | 1.00 | AHCY (0.55) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| SCHEMBL16214136 | 1.00 | AHCY (0.55) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| SCHEMBL16214114 | 0.91 | AHCY (0.54) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| SCHEMBL16214128 | 0.91 | AHCY (0.54) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| SCHEMBL13523527 | 0.90 | AHCY (0.59) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| SCHEMBL29548998 | 0.90 | AHCY (0.59) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| SCHEMBL31725310 | 0.89 | AHCY (0.56) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| SCHEMBL15204007 | 0.88 | AHCY (0.53) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| SCHEMBL16214074 | 0.88 | AHCY (0.41) | AHCYALDH1A1HIF1AADORA3PI4KA | |
| Phosphoric Acid SCHEMBL21465035 | 0.86 | AHCY (0.56) | AHCYALDH1A1HIF1AADORA3PI4KA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230277576-A1 | A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE | HENAN GENUINE BIOTECH CO., LTD. (CN) | 2023-09-07 | — | — | US | disclosed |
| EP-4112050-A1 | USE OF NUCLEOSIDE COMPOUND IN TREATMENT OF CORONAVIRUS INFECTIOUS DISEASES | Henan Genuine Biotech Co., Ltd. (CN) | 2023-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230277576-A1 | A METHOD FOR PREVENTING OR TREATING A CORNAVIRUS INFECTIOUS DISEASE | ACE, ACE2, SARS1 | AHCY 1014/4885ALDH1A1 2045/4885HIF1A 2277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.